Trial intelligence / Profile preview

TMI-005 in active rheumatoid arthritis on background methotrexate

2004-000012-13Phase 2Completed

Sponsor
Wyeth
Start
Nov 2004
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of apratastat in rheumatoid arthritis (RA) (4 arms), sponsored by Wyeth. Started Nov 2004; status: completed.

02

Drugs

apratastat
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on 2004-000012-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-000012-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call